Clinical Trial Update: Study of the Safety and Efficacy of Dichloroacetate (DCA) in Glioblastoma and Other Recurrent Brain Tumors [Phase 1]

View source ↗

Summary

This entry notes completion of a Phase 1 study evaluating dichloroacetate (DCA) for glioblastoma and other recurrent brain tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Dichloroacetate (dichloroacetate)

Snippet

Sponsor: University of Florida | Conditions: Brain Tumor, Glioblastoma | Phase 1 | Status: COMPLETED